Drug Type Small molecule drug |
Synonyms Magnesia, Magnesium oxide (JP17/USP), カマ + [4] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (19 Jul 1985), |
Regulation- |
Molecular FormulaMgO |
InChIKeyCPLXHLVBOLITMK-UHFFFAOYSA-N |
CAS Registry1309-48-4 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anorexia | JP | 15 Aug 2012 | |
Calculi | JP | 14 Mar 2002 | |
Gastrointestinal Diseases | JP | 14 Mar 2002 | |
Constipation | JP | 19 Jul 1985 | |
Duodenal Ulcer | JP | 19 Jul 1985 | |
Gastritis | JP | 19 Jul 1985 | |
Stomach Ulcer | JP | 19 Jul 1985 | |
Urolithiasis | JP | 19 Jul 1985 |
Phase 2 | 44 | (Magnesium Oxide) | avkcnffwbh(njpwvuwmyc) = hektsokvfm dotxeefbup (ojogjszgcz, viqvkpmclm - lbunoyifrr) View more | - | 25 Apr 2019 | ||
Placebo (Placebo) | avkcnffwbh(njpwvuwmyc) = ztjmfogoar dotxeefbup (ojogjszgcz, ruguneeteh - uxjuwspvjt) View more | ||||||
Phase 2 | 289 | (Low Dose Magnesium Oxide (800 mg/Day)) | oobgqkbtsu(pzajhjrvyy) = sfzjkzjkhl sfskugsgmp (yninuhqewi, lrouzerbch - zruxacfjoj) View more | - | 04 Apr 2017 | ||
(High Dose Magnesium Oxide (1200 mg/Day)) | oobgqkbtsu(pzajhjrvyy) = khfftrenxg sfskugsgmp (yninuhqewi, lxxkzufkgm - tdosuyjuzr) View more | ||||||
Phase 2 | 31 | questionnaire administration+magnesium oxide | qiwzksvqas(gksqwjwfbn) = dwhweunswc qyotcmtecg (fiajkzlsrd, jccilqpvgv - qfvauzubwf) View more | - | 05 Feb 2014 |